| 197 | 1 | 23 |
| 下载次数 | 被引频次 | 阅读次数 |
目的比较复方甘草酸苷注射液经肝动脉给药和腹腔给药对急性肝衰竭模型大鼠肝功能改善作用。方法用D-氨基半乳糖腹腔注射构建实验性急性肝衰竭模型大鼠。将复方甘草酸苷注射液经过肝动脉给药和腹腔给药两种途径作用于急性肝衰竭模型大鼠,并检测肝功能指标和观察大鼠肝组织病理变化。结果肝动脉灌注给药能明显改善大鼠的肝脏功能以及肝组织形态学,与腹腔给药组比较差异有高度统计学意义(P<0.01)。结论肝动脉灌注给药在改善急性肝衰竭大鼠肝功能方面优于腹腔给药。
Abstract：AIM To compare the therapeutic effects of compound glycyrrhizin injection by hepatic arterial infusion and by intraperitoneal injection on rats with acute hepatic failure.METHODS D-galactosamine was injected into the abdominal cavity of rats to establish an experimental model of acute liver failure.Rats of acute liver failure were treated with compound glycyrrhizin injection by hepatic arterial infusion and by intraperitoneal injection.The level of plasma ALT,AST,TBil and the pathological morphologies of hepatic tissues were examined.RESULTS Treatment of hepatic arterial infusion could obviously ameliorate the hepatic function and pathological morphologies of hepatic tissues of the rats.Comparing with intraperitoneal injection,there were statistical significances(P<0.01).CONCLUSION The improvement effects on liver function of experimental rats with acute hepatic failure by hepatic arterial infusion is better than by intraperitoneal injection.
[1]Ganeshan A,Upponi S,Hon LQ et al.Hepatic arterial infusion ofchemotherapy:the role of diagnostic and interventional radiology[J].Ann Oncol,2008,19(5):847.
[2]赖力英,杨旭,贺志军,等大鼠肝动脉插管给药途径的建立[J].中国比较医学杂志,2005,15(4):235.
[3]Guan LP,Nan JX,Jin XJ.Protective effects of chalcone derivatives foracute liver injuryin mice[J].Arch PharmRes,2005,28(1):81.
[4]Fukuda T,Mogami A,Tanaka H.Y-40138,a multiple eytokine produc-tion moludlator,protects anginst d-galaclosamine andlipopolysaccharide-induced hepatitis[J].Life Sci,2006,79(9):822.
[5]孙振球,徐勇勇.医学统计学[M].第2版.北京:人民卫生出版社,2005:289.
[6]石修权.多变量方差分析在医学实验中的运用[J].卫生软科学,2007,21(5):402.
[7]Kumada T,Sone Y,Toyoda H,et al.Hepatic arterial infusionchemotherapyfor colorectal liver metastases[J].Gan To Kagaku Ryoho,2004,31(5):700.
[8]Arai Y,Takeuchi Y,Inaba Y,et al.Percutaneous catheter placementfor hepatic arterial infusion chemotherapy[J].Tech Vasc Interv Radiol,2007,10(1):30.
[9]Tsutsumi S,Yamaguchi S,Tsuboi K,et al.Hepatic arterial infusion com-bined with oral UFT/UZELsystemic chemotherapyfor unresectable livermetastasis of colorectal cancer[J].Hepato Gastroenterol,2008,55(85):1419.
[10]郝强,田建明,曹雪涛等,经肝动脉插管注射重组腺病毒治疗大鼠转移性肝癌的实验研究[J].中华放射学杂志,2003,34(10):666.
[11]Atencio IA,Grace M,Bordens R,et al.Biological activities of a re-combinant adenovirus p53(SCH 58500)administered by hepaticarterial infusionin a phase 1 colorectal cancer trial[J].Cancer GeneTher,2006,13(2):169.
[12]Tada M,Hatano E,Taura K,et al.High volume hydrodynamic injec-tion of plasmid DNAviathe hepatic arteryresultsina highlevel of geneexpressioninrat hepatocellular carcinomainduced by diethylnitrosamine[J].Gene Med,2006,8(8):1018.
基本信息:
DOI：10.19577/j.cnki.issn10074406.2010.02.003
中图分类号:R285.5
引用信息:
[1]方年,范旭,何生松.复方甘草酸苷注射液不同给药途径对急性肝衰竭模型大鼠肝功能的影响[J].中国临床药学杂志,2010,19(02):77-80.DOI:10.19577/j.cnki.issn10074406.2010.02.003.
基金信息:
台州市科技局资助(编号051KY28)
2010-03-25
2010-03-25